Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC008533 | Panoply™ Human LAMP3 Knockdown Stable Cell Line | Inquiry |
| CSC-SC008533 | Panoply™ Human LAMP3 Over-expressing Stable Cell Line | Inquiry |
| CSC-RT1831 | LAMP3 Knockout Cell Line-HeLa | Inquiry |
| CSC-RT2177 | Human LAMP3 Knockout Cell Line-A549 | Inquiry |
| CLOE-1353 | Human LAMP3 HEK293 Cell Lysate | Inquiry |
| CLKO-1680 | LAMP3 KO Cell Lysate-HeLa | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD09003Z | Human LAMP3 adenoviral particles | Inquiry |
| LV16746L | human LAMP3 (NM_014398) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH141905 | shRNA set against Human LAMP3(NM_014398.3) | Inquiry |
| SHH328363 | shRNA set against Mouse LAMP3 (NM_177356.3) | Inquiry |
| SHH141923 | shRNA set against Rat Lamp3(NM_001012015.1) | Inquiry |
| SHH141941 | shRNA set against Mouse Lamp3(NM_177356.3) | Inquiry |
| SHH328359 | shRNA set against Human LAMP3 (NM_014398.3) | Inquiry |
| SHH328367 | shRNA set against Rat LAMP3 (NM_001012015.1) | Inquiry |
| SHW002870 | shRNA set against Chicken LAMP3 (NM_001146132) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCL185102 | Mouse LAMP3 ORF clone(NM_177356.3) | Inquiry |
| CDFL006815 | Mouse Lamp3 cDNA Clone(NM_177356.3) | Inquiry |
| CDFR002445 | Rat Lamp3 cDNA Clone(NM_001012015.1) | Inquiry |
| MiUTR1H-05568 | LAMP3 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-06521 | LAMP3 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-02955 | LAMP3 miRNA 3'UTR clone | Inquiry |
| CDCB156627 | Cynomolgus LAMP3 ORF clone | Inquiry |
| CDCB164345 | Chicken LAMP3 ORF Clone (NM_001146132) | Inquiry |
| CDCB186809 | Rabbit LAMP3 ORF clone (XM_008266569.1) | Inquiry |
| CDCR369362 | Rat Lamp3 ORF Clone(NM_001012015.1) | Inquiry |
Recent Progress
Lysosomal associated membrane protein 3 (LAMP3) is a tumor-specific and hypoxia-induced protein. It is a downstream target gene of tumor suppressor TP53 and its expression has been associated with hypoxia-induced metastasis and poor overall survival in cervical, breast and gastrointestinal cancers. It may also serve as a molecular marker of mature dendritic cells. Its expression was induced by hypoxia, and was associated with hypoxia mediated metastasis in breast and cervical cancers.
To determine LAMP3 protein expression in laryngeal squamous cell carcinoma (LSCC) and its prognostic value, researchers identified protein expression of LAMP3 and TP53 in LSCC tissues, which was correlated with patients' clinical parameters and overall survival. LAMP3 and TP53 protein expression was significantly higher in cancerous tissues compared to adjacent normal surgical margin tissues. Both high LAMP3 and high TP53 protein expression were significantly associated with tumor stage and size. Significant correlation between LAMP3 and TP53 expression was observed. Patients with high LAMP3 or high TP53 expression had a poor overall survival. These findings suggest that both epithelial LAMP3 expression and TP53 expression are independent prognostic markers for LSCC.
In another research, investigators determined protein expression of LAMP3 and TP53 in both gastric and colorectal tissues. It was revealed that LAMP3 and TP53 protein expression was significantly higher in cancerous tissues compared to normal and benign tissues. In both gastric and colorectal cancers, high LAMP3 protein expression was significantly associated with tumor stage. However no correlation between LAMP3 and TP53 expression was observed. Patients with high LAMP3 expression but not high TP53 expression had a poor overall survival. These findings suggest that epithelial LAMP3 expression is an independent prognostic marker for gastrointestinal cancer.
To elucidate the epithelial expression of LAMP3 and its prognostic value in esophageal squamous cell carcinoma (ESCC), mRNA expression of LAMP3 in 157 ESCC tissues and 50 adjacent normal tissues was detected by qRT-PCR. The results showed that both mRNA and protein expression level of LAMP3 were significantly higher in cancerous tissues compared with normal controls. LAMP3 DNA copy number was amplified in 70% of ESCC tissues and positive correlated with mRNA expression. Furthermore, patients with higher LAMP3 expression had worse overall survival and disease-free survival. In conclusion, these results suggest that epithelial LAMP3 expression is an independent prognostic biomarker for ESCC.
In order to examine the hypoxic regulation of the PKR-like endoplasmic reticulum kinase (PERK)/activating transcription factor-4 (ATF4)/LAMP3-arm of the unfolded protein response (UPR) in head and neck squamous cell carcinoma (HNSCC), LAMP3 expression was determined in patient biopsies. It was found that mRNA and protein expression for PERK, ATF4, and LAMP3 was evaluated after hypoxic exposure of HNSCC cell lines. Moreover, in patients with HNSCC, high LAMP3 expression and the occurrence of distant metastases during follow-up was discovered. Patients with high LAMP3 levels had a worse metastasis-free survival. Exposure to endoplasmic reticulum-stress stimulated PERK, ATF4, and LAMP3 expression. In conclusion, LAMP3 is relevant for prognosis in HNSCC. However, the PERK/ATF4/LAMP3-arm of the UPR responded differently to hypoxia in HNSCC compared to other tumor types.
References: